Blood Cancer
Showing 17–32 of 71 results
-
DEFENCATH (taurolidine, heparin)
Read more -
EBGLYSS (lebrikizumab-lbkz) injection
Read more -
ELREXFIO (elranatamab-bcmm) injection
Read more -
EMPLICITI (elotuzumab) for injection
Read more -
EPKINLY (epcoritamab-bysp) injection
Read more -
GAZYVA (obinutuzumab) injection, for intravenous infusion.
Read more -
ICLUSIG (ponatinib) tablets for oral use. Initial U.S. Approval: 2012
Read more -
IDHIFA (enasidenib) tablets, for oral use.
Read more -
IMLYGIC (talimogene laherparepvec). Suspension for intralesional injection
Read more -
Jakavi (ruxolitinib) Tablets
Read more -
JAYPIRCA (pirtobrutinib)
Read more -
JESDUVROQ (daprodustat)
Read more -
JYLAMVO (methotrexate) oral
Read more -
KEYTRUDA (pembrolizumab) injection, for intravenous use
Read more -
LIBTAYO (cemiplimab-rwlc) injection, for intravenous use. Initial U.S. Approval: 09/2018
Read more -
LUNSUMIO (mosunetuzumab-axgb) injection
Read more
